GlassScriptPhysician profile
Erich G Randolph
NPI 1598703456
$626.57
in general payments reported to CMS, 2019-2025
12 companies · $70.78 in 2025
The $70.78 reported for 2025 was less than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $149 · 2020: $17.89 · 2021: $211 · 2022: $89.16 · 2023: $75.67 · 2024: $13.84 · 2025: $70.78.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $160.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $160.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seagen INC. | $179.99 | 2021-2023 | Tukysa |
| Regeneron Healthcare Solutions, INC. | $123.10 | 2019-2025 | Libtayo |
| Incyte Corporation | $82.54 | 2021 | |
| Novartis Pharmaceuticals Corporation | $58.48 | 2019-2020 | |
| Celgene Corporation | $48.43 | 2022 | |
| Sumitomo Pharma America, INC. | $43.56 | 2025 | Orgovyx |
| Boston Scientific Corporation | $17.81 | 2019 | |
| Janssen Biotech, INC. | $15.98 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $15.28 | 2019 | |
| Taiho Oncology, INC. | $15.02 | 2019 | |
| Baxter Healthcare | $13.43 | 2019 | |
| Amgen INC. | $12.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erich Randolph listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.